Joint declaration – “Together for an effective global response to cholera”.

Joint declaration – “Together for an effective global response to cholera”.
Joint declaration – “Together for an effective global response to cholera”.

1/ As countries improve their water and sanitation infrastructure, we believe that vaccination is also an important and effective tool in the fight against cholera. To respond to the current cholera crisis, it is essential that the global supply of oral cholera vaccines (OCV) can meet the increased demand. Increasing the quantity and improving the distribution of oral cholera vaccine is essential for the long-term prevention and management of cholera outbreaks, alongside key multi-sectoral measures such as improving the quality of water, sanitation and hygiene (WASH), ensuring access to health care services, effective community engagement and strengthening diagnosis, surveillance and management of case, as part of our joint efforts to achieve the Sustainable Development Goals relating to access to safe drinking water and sanitation (SDG 6) and good health and well-being (SDG 3).

2/ We applaud the impact of the work of Gavi, the Vaccine Alliance, over the past decade, notably in shaping the market and providing programmatic and financial support for the expansion of supply and deployment of preventive use of cholera vaccines as well as the emergency stock of OCV, managed by the International Coordination Group (ICG) on Vaccine Supply to respond to outbreaks. Working with Alliance partners and countries since 2013, Gavi’s efforts have increased supply 18-fold and spurred a 30% increase in production in 2024 and much more in 2025 for vaccines against cholera. Collaboration between Gavi, the World Health Organization (WHO), UNICEF and the Global Task Force on Cholera Control (GTFCC) has been instrumental in supporting country demand for OCV and implementation effective vaccination campaigns against cholera.

3/ We further believe that it is essential to invest in VCO production capacity in Africa to diversify the market and improve rapid access in areas at risk in the event of future cholera epidemics. We welcome that the Africa Vaccine Production Accelerator (AVMA) is designed to support financing of regional production of vaccines against priority diseases, including cholera, in line with i) the GTFCC: a global roadmap for 2030 and ii) our priorities for pandemic prevention, preparedness and response (PPPR). We look forward to supporting this goal through appropriate channels.

Supported by :
– Government of Canada
– Government of France
– Government of Germany
– Government of Ireland
– Government of Italy
– Government of Japan
– Government of Spain
– Government of Sweden
– United States Government
– Government of Australia
– European Commission

[Traduit de l’anglais]



PREV Global childhood vaccination levels stagnated in 2023, leaving many children without life-saving protection
NEXT Crack and cocaine are exploding in Switzerland and that can be explained